Mayer Brown has advised H.I.G. Capital, a global private equity investment firm, on the acquisition of two regional shopping centres in the UK: The Kennet Centre in Newbury, Berkshire and the Kirkgate Centre in Bradford, West Yorkshire.

The 350,000 sq ft Kirkgate Centre was built in 1976 and was one of the original Arndale Centres. The 240,000 sq ft Kennet Centre was built in 1972.
The transaction represents H.I.G.'s 25th real estate investment in Europe since the start of 2013.

Danica Ejendomsselskab ApS has acquired the so-called "Tuborg Syd" plot in the Copenhagen suburb of Hellerup at a price of DKK 600-700m. Plesner assisted Danica Ejendomme with the transaction.
Danica Ejendomme has acquired the last plot in Tuborg Harbour from Carlsberg A/S. The 106.000 sqm plot is uniquely placed facing Oresund.

The acquisition of the plot is the first part of a new property project that will build approximately 53,500 sqm exclusive rented flats and owner-occupied flats.

It is expected that the project will be finished in 2020.

Mayer Brown advises AEW Europe and Teacher Retirement System of Texas on the acquisition of Festival Place shopping centre

London - Mayer Brown has advised AEW Europe, a leading European real estate investment manager and the Teacher Retirement System of Texas on the acquisition of Festival Place shopping centre in Basingstoke, Hampshire.

The 1.1 million sq ft shopping centre was purchased from TH Real Estate on behalf of a partnership between AEW Europe and the Teacher Retirement System of Texas.

An international life sciences transactions team from Norton Rose Fulbright recently advised ViiV Healthcare in its purchase of Bristol-Myers Squibb’s late-stage HIV research and development assets and, in a separate deal, in its agreement to acquire Bristol-Myers Squibb’s HIV portfolio of pre-clinical and discovery stage research assets.

Gide has advised Swiss Life Reim on the acquisition of a portfolio of three 4-star hotels, located in the centre of Paris, from a fund managed by Morgan Stanley Real Estate Investing (MSREI) and from Paris Inn Group.

The Gide team comprises partner Nadège Nguyen and Alice Mayer on corporate aspects; partner Laurent Modave and Alexandre Bochu on tax aspects; counsel Laetitia Lemercier and Aurélien de Casteja on financing aspects.

Macfarlanes has advised Guy’s and St Thomas’ Charity on the acquisition of the head lease of Becket House, a 146,000 sq ft office building opposite St Thomas’ hospital, for £112m.

As the existing freeholder, the Charity’s acquisition is a strategic move which will help facilitate the regeneration of the area around St Thomas’ hospital.

Wragge Lawrence Graham & Co's Energy team, led by partner Gareth Baker, has advised longstanding client Primrose Solar on the acquisition of three 5MW solar farms, one at Bedborough Farm, Wimborne, one in Merston, Chichester, and the third near Ashby-de-la-Zouch.

The Bedborough acquisition was finalised in June 2015, with Primrose acquiring the site from Wiltshire-based developer Solstice Renewables.

King & Wood Mallesons (KWM) advises DEXUS in acquiring the stapled securities in the Investa Office Fund.

DEXUS, Australia’s biggest listed office landlord, has secured the deal through entry into a implementation agreement under which stapled securityholders would receive 0.4240 DEXUS Securities and $0.8229 cash per each security if the proposal is approved at a meeting of members expected to be in March 2016.

The KWM team was led by partner Susan Hilliard, supported by senior associates Daniel Natale, Amanda Isouard and Miriam Kleiner.

Noerr has again advised Vonovia SE on a large portfolio transaction on the German real estate market. The Dax company intends to purchase 2,400 residential units from a joint venture held by the British real estate group Grainger and the US private equity firm Heitmann. The transaction is envisaged to be completed by year-end.

MUNICH (December 7, 2015) - McDermott advised Honeywell on its acquisition of Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.
 
The acquired business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications. The agreement is subject to customary closing conditions, including regulatory review.